🇺🇸 FDA
Patent

US 10426799

Methods for production of platelets from pluripotent stem cells and compositions thereof

granted A61KA61K35/19A61P

Quick answer

US patent 10426799 (Methods for production of platelets from pluripotent stem cells and compositions thereof) held by Astellas Institute for Regenerative Medicine expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Astellas Institute for Regenerative Medicine
Grant date
Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K35/19, A61P, A61P17/02, A61P33/06